Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

.

Source: Expert Opinion on Therapeutic Patents - May 27, 2019 Category: Drugs & Pharmacology Authors: Sayyed Mohammad Ismail Mahboubi Rabbani Afshin Zarghi Source Type: research